RNA ターゲティングは,CRISPR-Cas12a2の無差別なニュクレアスの活動を誘発する
Jack P K Bravo1, Thomson Hallmark2, Bronson Naegle2
1Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA.
Nature
|January 4, 2023
まとめ
CRISPRに関連したCas12a2酵素は,標的RNAと結合した後にRNAとDNAを分解する. 構造的な研究は,その活性化経路と集団レベルの免疫を与えるメカニズムを明らかにします.
科学分野:
- 分子生物学
- 構造生物学
- 遺伝学
背景:
- CRISPRに関連した (Cas) 核酸は,プロカリオットの適応免疫の重要な構成要素である.
- Cas12a2は,標的認識後に様々な核酸を分解することが知られているCRISPR核酶です.
- Cas12a2の活性化メカニズムを理解することは,そのバイオテクノロジーの応用にとって極めて重要です.
研究 の 目的:
- Cas12a2の活性化と作用メカニズムの構造的基礎を解明する.
- Cas12a2の完全な活性化経路を構造分析で明らかにする.
- Cas12a2が流産性感染症と集団レベルの免疫にどのように貢献するかについての洞察を提供するためです.
主な方法:
- 異なる複合状態 (バイナリ,三元,四元) のCas12a2の構造を決定するために,X線結晶学を用いた.
- 基質の分解と酵素の活性を研究するために生化学的測定法が用いられた可能性が高い.
- 免疫機能におけるCas12a2の役割を評価するために,in vivo実験を用いた.
主要な成果:
- Cas12a2は自己阻害性であり,活性化にはRNA標的結合が必要です.
- RNA結合はRuvC活性部位を露出させ,ssRNA,ssDNA,およびdsDNAの非特異的な分解を可能にします.
- 陽性電荷の裂け目と"芳香的クランプ"の残留を含む特殊な構造的特徴は,dsDNAの捕獲と分解を容易にする.
結論:
- この研究は,Cas12a2活性化経路に関する包括的な構造的理解を提供します.
- dsDNAの分解を含むCas12a2の作用機構は構造的に定義され,中断感染におけるその役割を説明する.
- これらの発見は,さまざまな用途に合わせた基板特異性を持つCas12a2の設計を導くことができます.
関連する概念動画
CRISPR/Cas9 Genome Editing
123
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
123
CRISPR
52.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.6K
CRISPR and crRNAs
17.2K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.2K
Homologous Recombination
50.8K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.8K
The Antiviral System of Bacteria and Archaea: CRISPR
86
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
86


